Marissa Fox is the Assistant Editor of Drug Topics ®.
Part 2: The Coadministration of COVID-19 and Flu VaccinesDecember 1st 2021
Kristen Nichols, PharmD, and senior content management consultant for clinical effectiveness at Wolters Kluwer joins Drug Topics® to discuss the benefits of the coadministration of COVID-19 and flu vaccines in part 2 of this interview.
Low Rate of Disease Flare Following Recombinant Zoster Vaccine in Immune Mediated Inflammatory DiseasesNovember 9th 2021
Patients with immune mediated inflammatory diseases are at an increased risk of herpes zoster, but research on the risk of possible vaccine-related flares following vaccination with the recombinant zoster vaccine is limited.
Socioeconomic Disadvantage Linked With Potentially Inappropriate Opioid PrescriptionsNovember 8th 2021
Patients who lived in socioeconomically disadvantaged areas were more likely to have potentially inappropriate opioid prescriptions, compared with other types of potentially inappropriate medications.
FDA Delays Adolescent COVID-19 Vaccine EUA Announcement for Moderna VaccineNovember 3rd 2021
The FDA has notified Moderna that it will need additional time to complete its evaluation of Moderna’s EUA request for the use of the company’s COVID-19 vaccine at the 100-µg dose level in adolescents between 12 and 17 years.
The Coadministration of COVID-19 and Flu Vaccines, Part 1October 29th 2021
Kristen Nichols, PharmD, and senior content management consultant for clinical effectiveness at Wolters Kluwer joins Drug Topics® to discuss the benefits of the coadministration of COVID-19 and flu vaccines in part 1 of this interview.
Increase Medication Adherence through Patient Relationships, Part 1October 27th 2021
Tony Makarich, PharmD and vice president of clinical services at Catalyst Health Rx, sits down with Drug Topics® to discuss the benefits of a relationship and team-based pharmacy model in part 1 of this 3-part interview.